The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Loravis 50 microgram/ml eye drops, solution

Zaklady Farmaceutyczne POLPHARMA S.A.PA22845/002/001

Main Information

Trade NameLoravis 50 microgram/ml eye drops, solution
Active SubstancesLatanoprost
Dosage FormEye drops, solution
Licence HolderZaklady Farmaceutyczne POLPHARMA S.A.
Licence NumberPA22845/002/001

Group Information

ATC CodeS01EE01 latanoprost


License statusAuthorised
Licence Issued07/01/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0096-152-045
Interchangeable List DocumentPDF of Interchangeable List
« Back